Pharmacokinetics optimization of antimicrobials: a stewardship approach for pediatric patients with pneumonia and hypoalbuminemia

Authors

DOI:

https://doi.org/10.30968/jhphs.2025.162.1314

Abstract

Objective: To evaluate whether pharmacokinetic optimization of beta-lactam antibiotics highly bound to plasma proteins prevent escalation to broader-spectrum antibiotics in pediatric patients with complicated CAP. Methods: Retrospective cohort study in a pediatric tertiary hospital, involving patients with complicated CAP treated with optimized doses of ceftriaxone and/or oxacillin, monitored by the antimicrobial stewardship program between 2023 and 2024. Patients admitted to the wards were included, excluding those in ICUs, hemato-oncology or with treatment time less than 48 hours. Data were collected from clinical records and analyzed using SPSS v2.0, including descriptive analyses (means, standard deviation, frequencies) and inferential tests (Mann-Whitney, Student’s t-test, Chi-Square/Fisher, p<0.05). The outcomes evaluated were clinical/microbiological cure, treatment failure, and augmented renal clearance. The study followed the STROBE guidelines and was approved by the Ethics Committee (CAAE: 77560624.9.0000.0097). Results: The sample included 53 patients, of which 96.2% had complicated CAP, high prevalence of hypoalbuminemia (92.5%) and augmented renal clearance (91.3%). There was a significant reduction in escalation in 2024 (from 48.3% to 8.3%; p=0.001), decreased in the time to intervention for therapy optimization (5th vs. 3rd day, p=0.004), and reduction in total treatment duration (12.2 vs. 9.5 days, p=0.011) after protocol implementation. No adverse reactions occurred, and clinical cure without escalation was observed in 69.8% of patients. Conclusion: Pharmacokinetic optimization of beta-lactam antibiotics was effective in reducing escalation in patients with complicated CAP. The pharmacist’s role in stewardship, contributed to better clinical outcomes and safety, with positive impacts on clinical practice and adherence to the protocol.

Downloads

Download data is not yet available.

References

Unicef. Pneumonia, 2024. Available in: https://data.unicef.org/topic/child-health/pneumonia/#status. Accessed on: May 12, 2025.

Mahtab S, Blau DM, Madewell ZJ, et al. Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study. Lancet Child Adolesc Health. 2024;8(3):201-213. doi:10.1016/S2352-4642(23)00328-0

de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020;396(10253):786-798. doi:10.1016/S0140-6736(20)31550-64.

Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-e76. doi:10.1093/cid/cir531

São Paulo, Secretaria de Estado de Saúde. Coordenadoria de Controle de Doenças. Instituto Adolfo Lutz. Boletim: Informação da vigilância das pneumonias e meningitis bacterianas: Sireva. 2024. Available in: https://www.ial.sp.gov.br/resources/insituto-adolfo-lutz/publicacoes/utf-8crudos-ial_2024_portal.pdf. Accessed on: May 12, 2024.

Prais D, Kuzmenko E, Amir J, Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics. 2008;121(3):e533-e538. doi:10.1542/peds.2007-0317

Ackerman A, Zook NR, Siegrist JF, Brummitt CF, Cook MM, Dilworth TJ. Comparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily. Antimicrob Agents Chemother. 2020;64(6):e00066-20. doi:10.1128/AAC.00066-20

Porat S, Bhatia N, Barnett DW. A child with severe pneumonia, pleural effusion and acute hypoalbuminemia. Clin Pediatr (Phila). 2002;41(3):199-200. doi:10.1177/000992280204100318.

Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?. Infect Dis Now. 2021;51(5):418-423. doi:10.1016/j.idnow.2021.05.004

Schenidt Bispo da Silva SC, Fachi MM, Ricieri MC, de Araújo Motta F. Pharmacist-led antimicrobial stewardship program in the treatment of Staphylococcus aureus bacteraemia in paediatric patients: a multivariate analysis. Infect Prev Pract. 2024;6(4):100419. doi:10.1016/j.infpip.2024.100419

Schleibinger M, Steinbach CL, Töpper C, et al. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. Br J Clin Pharmacol. 2015;80(3):525-533. doi:10.1111/bcp.12636

Cabral FL, Sestren B, Silva SCSB, et al. Análise da hipoalbuminemia em pacientes pediátricos com pneumonia adquirida na comunidade como oportunidade de otimização farmacocinética. Rev Min Epidemiologia e Controle de Infecção. Belo Horizonte: AMECI & SMI;2025; doi:10.29327/5477619.

Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet. 2011;50(2):99-110. doi:10.2165/11539220-000000000-00000

Arensman Hannan K, Draper E, Cole KC, Mc Hugh J, Rivera CG, Abu Saleh O. Impact of hypoalbuminemia on clinical outcomes among patients with obesity treated with ceftriaxone. Antimicrob Agents Chemother. 2024;68(4):e0166323. doi:10.1128/aac.01663-23

Ackerman A, Zook NR, Siegrist JF, Brummitt CF, Cook MM, Dilworth TJ. Comparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily. Antimicrob Agents Chemother. 2020;64(6):e00066-20. doi:10.1128/AAC.00066-20

Kopač M. Acute Kidney Injury in Children: Classification, Recognition and Treatment Principles. Children (Basel). 2024;11(11):1308. doi:10.3390/children11111308.

Adams SM, Ngo L, Morphew T, Babbitt CJ. Does an Antimicrobial Time-Out Impact the Duration of Therapy of Antimicrobials in the PICU?. Pediatr Crit Care Med. 2019;20(6):560-567. doi:10.1097/PCC.0000000000001925

Viasus D, Garcia-Vidal C, Simonetti A, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect. 2013;66(5):415-423. doi:10.1016/j.jinf.2012.12.007

Downloads

Published

2025-06-30

How to Cite

1.
SESTREN B, ANDRADE BD, SILVA SS, BINDEMANN D, CABRAL FL, SECHTA TL, CAMARGO MM, MOTTA FA, RICIERI MC. Pharmacokinetics optimization of antimicrobials: a stewardship approach for pediatric patients with pneumonia and hypoalbuminemia. J Hosp Pharm Health Serv [Internet]. 2025Jun.30 [cited 2025Jul.1];16(2):e1314. Available from: https://jhphs.org/sbrafh/article/view/1314

Issue

Section

ORIGINAL ARTICLES